Acrivon Therapeutics, Inc. Uncategorized Contracts & Agreements
7 Contracts & Agreements
- Form of Letter Agreement, dated April 8, 2024, by and among Acrivon Therapeutics, Inc. and each of the persons party thereto (Filed With SEC on April 9, 2024)
- Form of Letter Agreement, dated April 8, 2024, by and among Acrivon Therapeutics, Inc. and each of the persons party thereto (Filed With SEC on April 9, 2024)
- Third Amendment to OncoSignature Companion Diagnostic Agreement, by and between the Registrant and Akoya Biosciences, Inc., dated December 4, 2023 (Filed With SEC on March 28, 2024)
- Second Amendment to OncoSignature Companion Diagnostic Agreement, by and between Acrivon Therapeutics, Inc. and Akoya Biosciences, Inc., dated June 19, 2023 (Filed With SEC on March 28, 2024)
- Description of registrants securities (Filed With SEC on March 28, 2024)
- Second Amendment to OncoSignature Companion Diagnostic Agreement, by and between Acrivon Therapeutics, Inc. and Akoya Biosciences, Inc., dated June 19, 2023 (Filed With SEC on August 11, 2023)
- OncoSignature Companion Diagnostic Agreement, by and between the Registrant and Akoya Biosciences, Inc., dated June 17, 2022 (Filed With SEC on October 17, 2022)